These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Drug patent plan gets mixed reviews. Butler D Nature; 2009 Feb; 457(7233):1064. PubMed ID: 19256077 [No Abstract] [Full Text] [Related]
6. Overcoming the challenges in the pharma/biotech industry. Graul AI; Prous JR Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900 [TBL] [Abstract][Full Text] [Related]
7. IP litigation in China could drive innovation. Jia H Nat Biotechnol; 2004 Apr; 22(4):368. PubMed ID: 15060539 [No Abstract] [Full Text] [Related]
8. Reference pricing of pharmaceuticals. Brekke KR; Königbauer I; Straume OR J Health Econ; 2007 May; 26(3):613-42. PubMed ID: 17188769 [TBL] [Abstract][Full Text] [Related]
9. Five years on...and four challenges for the pharmaceutical industry. Nat Rev Drug Discov; 2007 Jan; 6(1):3. PubMed ID: 17269156 [No Abstract] [Full Text] [Related]
10. The use of generic or patent medicines in the Netherlands. Gebhardt DO J Med Ethics; 2005 Jul; 31(7):409. PubMed ID: 15994361 [No Abstract] [Full Text] [Related]
11. Overcoming the obstacles in the pharma/biotech industry: 2008 update. Graul AI; Revel L; Rosa E; Cruces E Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298 [TBL] [Abstract][Full Text] [Related]
12. Patent. Battle lines are drawn over generic AIDS drug. AIDS Policy Law; 2005 Aug; 20(16):6. PubMed ID: 16161208 [No Abstract] [Full Text] [Related]
14. Effects of patent abolition on the drug industry. SMITH A Appl Ther; 1963 May; 5():433-7. PubMed ID: 13993111 [No Abstract] [Full Text] [Related]
15. [Similarity of biotechnology-derived drugs: regulatory framework and specificity]. Prugnaud JL Ann Pharm Fr; 2008 Aug; 66(4):206-11. PubMed ID: 18847566 [TBL] [Abstract][Full Text] [Related]
16. Are patent expirations the answer to improving patient adherence? Klepser DG Am J Manag Care; 2008 Dec; 14(12):787-8. PubMed ID: 19067495 [No Abstract] [Full Text] [Related]
17. [The patent is "engine" in drug development]. Bergström R Lakartidningen; 2008 Mar 5-11; 105(10):752. PubMed ID: 18422246 [No Abstract] [Full Text] [Related]
18. The interaction between intellectual property and drug regulatory systems: global perspectives. Madden EA IDrugs; 2007 Feb; 10(2):116-20. PubMed ID: 17285464 [TBL] [Abstract][Full Text] [Related]
19. Biotechs go generic: the same but different. Ledford H Nature; 2007 Sep; 449(7160):274-6. PubMed ID: 17882194 [No Abstract] [Full Text] [Related]